MSC-delivered High-Affinity Variants of Soluble PD1 Lead to Tumour Regression
Authors:
- Serap GokcenSGSerap Gokcen
- Tianyuan ChuTCTianyuan Chu
- Phoebe Elizabeth BlairPBPhoebe Elizabeth Blair
- Natalia KrajewskaNKNatalia Krajewska
- Greg BrookeGBGreg Brooke
- Stuart RushworthSRStuart Rushworth
- Philippe Pierre LaissuePLPhilippe Pierre Laissue
- Ralf Michael ZwackaRZRalf Michael Zwacka
- Andrea MohrAMAndrea Mohr
- 11 June 2026
- journal article
- Published by Elsevier in Cytotherapy
- Vol. 28 (11)
Abstract
No abstract availableFunding Information
- Bowel Cancer UK (24PG0009)
- Pancreatic Cancer UK (EDG2023-24_Teif)
This publication has 77 references indexed in Scilit:
- Durvalumab Alone or Combined With Novel Agents for Unresectable Stage III Non–Small Cell Lung CancerJAMA Network Open, 2025
- Immune checkpoint inhibitors in cancer therapy: what lies beyond monoclonal antibodies?Medical Oncology, 2025
- Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitmentCancer Cell, 2023
- Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockadeDiabetologia, 2022
- Fas-threshold signalling in MSCs promotes pancreatic cancer progression and metastasisCancer Letters, 2021
- Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation programCancer Immunology, Immunotherapy, 2021
- The future of mesenchymal stem cell-based therapeutic approaches for cancer – From cells to ghostsCancer Letters, 2018
- Targeting of XIAP Combined with Systemic Mesenchymal Stem Cell-Mediated Delivery of sTRAIL Ligand Inhibits Metastatic Growth of Pancreatic Carcinoma CellsStem Cells, 2010
- Large‐scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: Implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cellsArthritis & Rheumatism, 2010
- Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.The EMBO Journal, 1992